Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pilot Study of Trastuzumab in Combination With Gemcitabine Plus Cisplatin for HER2-positive Biliary Tract Cancer

NCT03613168 is registered in ClinicalTrials.gov with Changhoon Yoo as lead sponsor.

NCT NCT03613168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03613168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pilot Study of Trastuzumab in Combination With Gemcitabine Plus Cisplatin for HER2-positive Biliary Tract Cancer
Lead sponsor
Changhoon Yoo
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2019
Completion date
January 4, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer, cholangiocarcinoma, her-2 gene amplification, her-2 protein overexpression